Cerus Corp. (CERS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1220 CONCORD AVENUE CONCORD, CA 94520

Cerus Corp. develops medical systems and therapeutics based on its proprietary Helinx technology for controlling biological replication. The company's programs are focused on systems to enhance the safety of blood products used for transfusion, using its Listeria vaccine platform.

Data as of 2020-11-22
Market Cap1.041 Billion Shares Outstanding167.142 Million Avg 30-day Volume1.471 Million
P/E Ratio-16.0 Dividend Yield EPS-0.39
Price/Sales9.718 Price cash flow ratio Price free cash flow ratio-24.5
Book Value0.65 Price to Tangible Book9.65 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.106934
BETA1.2205 52-week High/Low7.94 / 2.71 Stddev0.157283
View SEC Filings from CERS instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 160 159 0.63% 44 (2.89%) 43 (2.79%) 2.33%
13F shares: 137.094 Million 135.567 Million 1.13% 59.187 Million 54.613 Million 8.38%
% Ownership 82.5019 81.5826 1.13% 35.6182 32.8653 8.38%
New Positions: 24 29 -17.24% 10 9 11.11%
Increased Positions 52 59 -11.86% 11 13 -15.38%
Closed Positions 19 19 0.0% 8 6 33.33%
Reduced Positions 50 41 21.95% 16 12 33.33%
Total Calls 487.616 Thousand 653.374 Thousand -25.37% 76.4 Thousand 51.8 Thousand 47.49%
Total Puts 371.97 Thousand 391.294 Thousand -4.94% 42.4 Thousand 35.4 Thousand 19.77%
PUT/CALL Ratio 0.76 0.6 26.67% 0.55 0.68 -19.12%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CERS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CERS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

42.9 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

14.3 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SWISHER DANIEL N JR

  • Director
59,868 2020-11-17 4

GREEN KEVIN DENNIS CHIEF FINANCIAL OFFICER

  • Officer
99,468 2020-11-10 3

BJERKHOLT ERIC

  • Director
28,563 2020-10-05 3

MOORE TIMOTHY L.

  • Director
12,207 2020-09-05 5

JAYARAMAN VIVEK K CHIEF COMMERCIAL OFFICER

  • Officer
160,003 2020-08-29 2

GREENMAN WILLIAM MARINER PRESIDENT AND CEO

  • Officer
  • Director
925,849 2020-08-26 2

ANDERSON TIMOTHY B

  • Director
210,101 2020-08-24 5

BENJAMIN RICHARD J CHIEF MEDICAL OFFICER

  • Officer
41,763 2020-08-24 3

MOORE CAROL SVP REG. & QUALITY

  • Officer
120,130 2020-08-12 4

MENARD CHRYSTAL CHIEF LEGAL OFFICER

  • Officer
48,585 2020-08-07 3

SCHULZE GAIL

  • Director
47,393 2020-06-05 3

WITNEY FRANK

  • Director
71,489 2020-06-05 3

NACHTSHEIM JAMI K

  • Director
0 2020-06-03 3

CORASH LAURENCE M CHIEF SCIENTIFIC OFFICER

  • Officer
1,897,558 2020-04-22 2

COZADD BRUCE C

  • Director
18,921 2017-06-06 0

HOGEBOOM CASPAR JAN PRESIDENT, CERUS EUROPE

  • Officer
0 2015-12-10 0

CASSIN BJ

  • Director
332,225 2013-11-04 0

ERVIN HOWARD G VICE PRESIDENT, LEGAL AFFAIRS

  • Officer
42,846 2013-01-07 0

GLASSELL CLAES EXECUTIVE OFFICER AND DIRECTOR

  • Officer
  • Director
0 2011-04-01 0

ROHN WILLIAM R

  • Director
0 2011-01-03 0

DAWSON WILLIAM J CHIEF FINANCIAL OFFICER

  • Officer
0 2009-01-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SWISHER DANIEL N JR - Director

2020-11-19 17:07:38 -0500 2020-11-17 S 10,000 $6.25 d 59,868 direct 0.4013 6.7416 6.7416 6 -5.7785 3

SWISHER DANIEL N JR - Director

2020-11-19 17:07:38 -0500 2020-11-17 M 10,000 $2.90 a 69,868 direct 0.4013 6.7416 6.7416 6 -5.7785 3

SWISHER DANIEL N JR - Director

2020-11-19 17:07:38 -0500 2020-11-17 M 10,000 d 15,000 direct

GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-11-12 18:57:12 -0500 2020-11-10 S 2,143 $5.51 d 130,253 direct -0.4934 2.4671 5.0987 3 -0.4934 2

GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-11-12 18:57:12 -0500 2020-11-10 S 30,785 $5.49 d 99,468 direct -0.4934 2.4671 5.0987 3 -0.4934 2

BJERKHOLT ERIC - Director

2020-10-06 17:58:14 -0400 2020-10-05 M 4,281 a 28,563 direct 0.3814 2.8223 -3.585 4.0427 3 -19.9085 18

BJERKHOLT ERIC - Director

2020-10-06 17:58:14 -0400 2020-10-05 M 4,281 d 4,281 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments